ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Hosted by NCSC USMirror sites:Canada China Korea Switzerland Taiwan
Search for

NiceProt View of Swiss-Prot: P02545

[General] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
General information about the entry
Entry name LAMA_HUMAN
Primary accession number P02545
Secondary accession numbers P02546 Q969I8 Q96JA2
Entered in Swiss-Prot in Release 01, July 1986
Sequence was last modified in Release 04, March 1987
Annotations were last modified in    Release 41, February 2003
Name and origin of the protein
Protein name Lamin A/C
Synonym 70 kDa lamin
Gene name
LMNA or LMN1
From
Homo sapiens (Human) [TaxID: 9606]
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo.
References
[1]
SEQUENCE FROM NUCLEIC ACID (ISOFORMS A AND C).
MEDLINE=86118697; PubMed=3453101; [NCBI, ExPASy, EBI, Israel, Japan]
McKeon F.D., Kirschner M.W., Caput D.;
"Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins.";
Nature 319:463-468(1986).
[2]
SEQUENCE FROM NUCLEIC ACID (ISOFORMS A AND C), AND SEQUENCE OF 583-644.
MEDLINE=86313596; PubMed=3462705; [NCBI, ExPASy, EBI, Israel, Japan]
Fisher D.Z., Chaudhary N., Blobel G.;
"cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins.";
Proc. Natl. Acad. Sci. U.S.A. 83:6450-6454(1986).
[3]
SEQUENCE FROM NUCLEIC ACID (ISOFORM C).
TISSUE=Kidney, and Lung;
Strausberg R.;
Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
[4]
SEQUENCE OF 375-664 FROM NUCLEIC ACID (ISOFORM ADELTA10).
TISSUE=Colon;
MEDLINE=96199170; PubMed=8621584; [NCBI, ExPASy, EBI, Israel, Japan]
Machiels B.M., Zorenc A.H., Endert J.M., Kuijpers H.J., van Eys G.J., Ramaekers F.C., Broers J.L.;
"An alternative splicing product of the lamin A/C gene lacks exon 10.";
J. Biol. Chem. 271:9249-9253(1996).
[5]
VARIANTS EDMD TRP-453; PRO-527 AND PRO-530.
MEDLINE=99178265; PubMed=10080180; [NCBI, ExPASy, EBI, Israel, Japan]
Bonne G., Di Barletta M.R., Varnous S., Becane H.-M., Hammouda E.-H., Merlini L., Muntoni F., Greenberg C.R., Gary F., Urtizberea J.-A., Duboc D., Fardeau M., Toniolo D., Schwartz K.;
"Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.";
Nat. Genet. 21:285-288(1999).
[6]
VARIANTS CMD1A GLY-60; ARG-85; LYS-195 AND GLY-203.
MEDLINE=20037766; PubMed=10580070; [NCBI, ExPASy, EBI, Israel, Japan]
Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M., Atherton J., Vidaillet H.J. Jr., Spudich S., De Girolami U., Seidman J.G., Seidman C.E.;
"Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.";
New Engl. J. Med. 341:1715-1724(1999).
[7]
VARIANT EDMD TYR-222.
MEDLINE=20206333; PubMed=10739764; [NCBI, ExPASy, EBI, Israel, Japan]
Raffaele di Barletta M., Ricci E., Galluzzi G., Tonali P., Mora M., Morandi L., Romorini A., Voit T., Orstavik K.H., Merlini L., Trevisan C., Biancalana V., Housmanowa-Petrusewicz I., Bione S., Ricotti R., Schwartz K., Bonne G., Toniolo D.;
"Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.";
Am. J. Hum. Genet. 66:1407-1412(2000).
[8]
VARIANT FPLD GLN-482.
MEDLINE=20056129; PubMed=10587585; [NCBI, ExPASy, EBI, Israel, Japan]
Cao H., Hegele R.A.;
"Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy.";
Hum. Mol. Genet. 9:109-112(2000).
[9]
VARIANTS FPLD LEU-482 AND TRP-482.
MEDLINE=20120714; PubMed=10655060; [NCBI, ExPASy, EBI, Israel, Japan]
Shackleton S., Lloyd D.J., Jackson S.N.J., Evans R., Niermeijer M.F., Singh B.M., Schmidt H., Brabant G., Kumar S., Durrington P.N., Gregory S., O'Rahilly S., Trembath R.C.;
"LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.";
Nat. Genet. 24:153-156(2000).
[10]
VARIANTS FPLD ASP-465; GLN-482; TRP-482 AND HIS-582.
MEDLINE=20206314; PubMed=10739751; [NCBI, ExPASy, EBI, Israel, Japan]
Speckman R.A., Garg A., Du F., Bennett L., Veile R., Arioglu E., Taylor S.I., Lovett M., Bowcock A.M.;
"Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.";
Am. J. Hum. Genet. 66:1192-1198(2000).
Comments
  • FUNCTION: LAMINS ARE COMPONENTS OF THE NUCLEAR LAMINA, A FIBROUS LAYER ON THE NUCLEOPLASMIC SIDE OF THE INNER NUCLEAR MEMBRANE, WHICH IS THOUGHT TO PROVIDE A FRAMEWORK FOR THE NUCLEAR ENVELOPE AND MAY ALSO INTERACT WITH CHROMATIN. LAMIN A AND C ARE PRESENT IN EQUAL AMOUNTS IN THE LAMINA OF MAMMALS.
  • SUBUNIT: HOMODIMER OF LAMIN A AND LAMIN C. INTERACTS WITH LAMIN-ASSOCIATED POLYPEPTIDES IA AND IB AND WITH EMERIN.
  • SUBCELLULAR LOCATION: Nuclear.
  • ALTERNATIVE PRODUCTS: 3 isoforms; Lamin A (shown here), Lamin C and ADelta10/Lamin ADelta10; are produced by alternative splicing.
  • PTM: INCREASED PHOSPHORYLATION OF THE LAMINS OCCURS BEFORE ENVELOPE DISINTEGRATION AND PROBABLY PLAYS A ROLE IN REGULATING LAMIN ASSOCIATIONS.
  • DISEASE: DEFECTS IN LMNA ARE A CAUSE OF EMERY-DREIFUSS MUSCULAR DYSTROPHY (EDMD), AN AUTOSOMAL RECESSIVE OR DOMINANT DISEASE CHARACTERIZED BY CARDIOMYOPATHY WITH CONDUCTION DEFECTS.
  • DISEASE: DEFECTS IN LMNA ARE A CAUSE OF DILATED CARDIOMYOPATHY 1A (CMD1A).
  • DISEASE: DEFECTS IN LMNA ARE A CAUSE OF FAMILIAL PARTIAL LIPODYSTROPHY (DUNNIGAN VARIETY) (FPLD), AN AUTOSOMAL DOMINANT DISORDER CHARACTERIZED BY MARKED LOSS OF SUBCUTANEOUS ADIPOSE TISSUE FROM THE EXTREMITIES AND TRUNK BUT BY EXCESS FAT DEPOSITION IN THE HEAD AND NECK. FREQUENTLY ASSOCIATED WITH PROFOUND INSULIN RESISTANCE, DYSLIPIDEMIA, AND DIABETES.
  • MISCELLANEOUS: THERE ARE THREE TYPES OF LAMINS IN HUMAN CELLS: A, B, AND C.
  • MISCELLANEOUS: THE STRUCTURAL INTEGRITY OF THE LAMINA IS STRICTLY CONTROLLED BY THE CELL CYCLE, AS SEEN BY THE DISINTEGRATION AND FORMATION OF THE NUCLEAR ENVELOPE IN PROPHASE AND TELOPHASE, RESPECTIVELY.
  • SIMILARITY: BELONGS TO THE INTERMEDIATE FILAMENT FAMILY.
  • CAUTION: Ref.1 (CAA27173) sequence differs from that shown due to a frameshift in position 582.
Copyright
This SWISS-PROT entry is copyright. It is produced through a collaboration between the Swiss Institute of Bioinformatics and the EMBL outstation - the European Bioinformatics Institute. There are no restrictions on its use by non-profit institutions as long as its content is in no way modified and this statement is not removed. Usage by and for commercial entities requires a license agreement (See http://www.isb-sib.ch/announce/ or send an email to license@isb-sib.ch).
Cross-references
EMBL
X03444; CAA27173.1; ALT_FRAME.[EMBL / GenBank / DDBJ] [CoDingSequence]
X03445; CAA27174.1; -.[EMBL / GenBank / DDBJ] [CoDingSequence]
M13451; AAA36164.1; -.[EMBL / GenBank / DDBJ] [CoDingSequence]
M13452; AAA36160.1; -.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC000511; AAH00511.1; -.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC003162; AAH03162.1; -.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF381029; AAK59326.1; -.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A02961; VEHULA.
A02962; VEHULC.
B24249; B24249.
A24249; A24249.
SWISS-2DPAGE P02545; HUMAN.
Genew HGNC:6636; LMNA.
CleanEx HGNC:6636; LMNA.
MIM 150330 [NCBI / EBI].
181350 [NCBI / EBI].
604929 [NCBI / EBI].
115200 [NCBI / EBI].
151660 [NCBI / EBI].
GeneCards LMNA.
GeneLynx LMNA; Homo sapiens.
SOURCE LMNA; Homo sapiens.
Ensembl P02545; Homo sapiens. [Entry / Contig view]
InterPro IPR001664; IF.
IPR001322; IF_tail.
Graphical view of domain structure.
Pfam PF00038; filament; 1.
PF00932; IF_tail; 1.
PROSITE PS00226; IF; 1.
ProDom [Domain structure / List of seq. sharing at least 1 domain].
BLOCKS P02545.
ProtoNet P02545.
ProtoMap P02545.
PRESAGE P02545.
DIP P02545.
ModBase P02545.
Keywords
Intermediate filament; Coiled coil; Nuclear protein; Lipoprotein; Prenylation; Phosphorylation; Alternative splicing; Disease mutation; Cardiomyopathy.
Features
KeyFrom   To Length Description
MOD_RES   1     1        BLOCKED.
DOMAIN   1    33  33     HEAD.
DOMAIN   34   383  350     ROD.
DOMAIN   384   664  281     TAIL.
DOMAIN   34    70  37     COIL 1A.
DOMAIN   71    80  10     LINKER 1.
DOMAIN   81   218  138     COIL 1B.
DOMAIN   219   242  24     LINKER 2.
DOMAIN   243   383  141     COIL 2.
SITE   325   325  1     STUTTER (BY SIMILARITY).
DOMAIN   417   422  6     NUCLEAR LOCALIZATION SIGNAL (POTENTIAL).
LIPID   661   661        FARNESYL (BY SIMILARITY).
VARSPLIC   537   566        MISSING (IN ISOFORM ADELTA10).
VARSPLIC   567   572        GSHCSS -> VSGSRR (IN ISOFORM LAMIN C).
VARSPLIC   573   664        MISSING (IN ISOFORM LAMIN C).
VARIANT   45    45        Y -> C (IN EDMD).
/FTId=VAR_009971.
VARIANT   50    50        R -> P (IN EDMD).
/FTId=VAR_009972.
VARIANT   60    60        R -> G (IN CMD1A).
/FTId=VAR_009973.
VARIANT   63    63        I -> S (IN EDMD).
/FTId=VAR_009974.
VARIANT   85    85        L -> R (IN CMD1A).
/FTId=VAR_009975.
VARIANT   112   112        MISSING (IN EDMD).
/FTId=VAR_009976.
VARIANT   195   195        N -> K (IN CMD1A).
/FTId=VAR_009977.
VARIANT   203   203        E -> G (IN CMD1A).
/FTId=VAR_009978.
VARIANT   222   222        H -> Y (IN EDMD).
/FTId=VAR_009979.
VARIANT   249   249        R -> Q (IN EDMD).
/FTId=VAR_009980.
VARIANT   261   261        MISSING (IN EDMD).
/FTId=VAR_009981.
VARIANT   294   294        Q -> P (IN EDMD).
/FTId=VAR_009982.
VARIANT   336   336        R -> Q (IN EDMD).
/FTId=VAR_009983.
VARIANT   343   343        R -> Q (IN EDMD).
/FTId=VAR_009984.
VARIANT   358   358        E -> K (IN EDMD).
/FTId=VAR_009985.
VARIANT   371   371        M -> K (IN EDMD).
/FTId=VAR_009986.
VARIANT   386   386        R -> K (IN EDMD).
/FTId=VAR_009987.
VARIANT   453   453        R -> W (IN EDMD).
/FTId=VAR_009988.
VARIANT   465   465        G -> D (IN FPLD).
/FTId=VAR_009989.
VARIANT   469   469        I -> T (IN EDMD).
/FTId=VAR_009990.
VARIANT   482   482        R -> L (IN FPLD).
/FTId=VAR_009991.
VARIANT   482   482        R -> Q (IN FPLD).
/FTId=VAR_009992.
VARIANT   482   482        R -> W (IN FPLD).
/FTId=VAR_009993.
VARIANT   486   486        K -> N (IN FPLD).
/FTId=VAR_009994.
VARIANT   527   527        R -> P (IN EDMD).
/FTId=VAR_009995.
VARIANT   528   528        T -> K (IN EDMD).
/FTId=VAR_009996.
VARIANT   530   530        L -> P (IN EDMD).
/FTId=VAR_009997.
VARIANT   582   582        R -> H (IN FPLD).
/FTId=VAR_009998.
FT aligner logo Feature aligner
SEVIEWER logo Feature table viewer
Sequence information
Length: 664 AA Molecular weight: 74139 Da CRC64: E0855F7699F0318B [This is a checksum on the sequence]
        10         20         30         40         50         60 
         |          |          |          |          |          | 
METPSQRRAT RSGAQASSTP LSPTRITRLQ EKEDLQELND RLAVYIDRVR SLETENAGLR 

        70         80         90        100        110        120 
         |          |          |          |          |          | 
LRITESEEVV SREVSGIKAA YEAELGDARK TLDSVAKERA RLQLELSKVR EEFKELKARN 

       130        140        150        160        170        180 
         |          |          |          |          |          | 
TKKEGDLIAA QARLKDLEAL LNSKEAALST ALSEKRTLEG ELHDLRGQVA KLEAALGEAK 

       190        200        210        220        230        240 
         |          |          |          |          |          | 
KQLQDEMLRR VDAENRLQTM KEELDFQKNI YSEELRETKR RHETRLVEID NGKQREFESR 

       250        260        270        280        290        300 
         |          |          |          |          |          | 
LADALQELRA QHEDQVEQYK KELEKTYSAK LDNARQSAER NSNLVGAAHE ELQQSRIRID 

       310        320        330        340        350        360 
         |          |          |          |          |          | 
SLSAQLSQLQ KQLAAKEAKL RDLEDSLARE RDTSRRLLAE KEREMAEMRA RMQQQLDEYQ 

       370        380        390        400        410        420 
         |          |          |          |          |          | 
ELLDIKLALD MEIHAYRKLL EGEEERLRLS PSPTSQRSRG RASSHSSQTQ GGGSVTKKRK 

       430        440        450        460        470        480 
         |          |          |          |          |          | 
LESTESRSSF SQHARTSGRV AVEEVDEEGK FVRLRNKSNE DQSMGNWQIK RQNGDDPLLT 

       490        500        510        520        530        540 
         |          |          |          |          |          | 
YRFPPKFTLK AGQVVTIWAA GAGATHSPPT DLVWKAQNTW GCGNSLRTAL INSTGEEVAM 

       550        560        570        580        590        600 
         |          |          |          |          |          | 
RKLVRSVTVV EDDEDEDGDD LLHHHHGSHC SSSGDPAEYN LRSRTVLCGT CGQPADKASA 

       610        620        630        640        650        660 
         |          |          |          |          |          | 
SGSGAQVGGP ISSGSSASSV TVTRSYRSVG GSGGGSFGDN LVTRSYLLGN SSPRTQSPQN 



CSIM 

P02545 in FASTA format

View entry in original Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Search the SWISS-MODEL Repository
ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Hosted by NCSC USMirror sites:Canada China Korea Switzerland Taiwan